Q. Almac has gained meaningful outcomes through past participation in BIX and is now joining as a major sponsor for the first time. Based on your previous experience, could you briefly share the background of this sponsorship decision and the key objectives you aim to achieve?

A. Almac’s major sponsor of BIX 2025 builds on the success of previous participation, where the company saw strong outcomes in visibility and engagement. This year, the goal is to elevate brand presence, showcase expertise in both clinical and commercial supply and drive strategic growth. Through a featured speaking session and premium booth presence, Almac aims to highlight its flexible packaging solutions and global supply agility. The sponsorship also supports deeper client engagement and cross-business collaboration, reinforcing Almac’s position as a strategic CDMO partner.

Q. What is Almac’s vision for the future of clinical trial drug development and customized supply chain markets, and what core strategies are you pursuing to address these opportunities?

A. Almac envisions a future where clinical and commercial supply chains are agile, integrated and patient-centric. Core strategies include global infrastructure investment, digital platforms, lifecycle continuity and flexible, client-driven solutions to accelerate development and delivery across the entire drug development pipeline.

Q. Could you highlight Almac’s unique strengths and the innovative technologies or services you plan to showcase at your BIX booth and conference sessions?

A. Almac will spotlight its strengths in integrated clinical and commercial supply solutions, global scalability and innovation. The booth will showcase its wide and flexible service offering.  Conference sessions will highlight Almac’s leadership in agile supply chain models and patient-centric delivery, reinforcing its role as a trusted partner in drug development, clinical packaging, manufacturing and commercial supply.

Q. How do you expect Almac to lead the market through BIX 2025, and what key messages do you wish to communicate to visitors and partners?

A. At BIX 2025, Almac will lead by showcasing its deep expertise and experience as an established, reliable CDMO through integrated clinical and commercial supply solutions, global scalability and client-focused innovation. Key messages include our commitment to agile delivery, end-to-end lifecycle support and trusted partnership.